Is S.M.B. TECHNOLOGY still active?

Yes, S.M.B. TECHNOLOGY is currently active.

Where is S.M.B. TECHNOLOGY registered?

S.M.B. TECHNOLOGY's registered address is Marche, Rue du Parc Industriel 39, 6900 Marche-en-Famenne, Belgium.

How many employees does S.M.B. TECHNOLOGY have?

Based on its most recently filed annual accounts (fiscal year ending 31 Dec 2025), S.M.B. TECHNOLOGY reported 129 full-time equivalent employees.

What is S.M.B. TECHNOLOGY's annual turnover?

S.M.B. TECHNOLOGY's most recently filed annual turnover (fiscal year ending 31 Dec 2025) was €94,515,569.

Did S.M.B. TECHNOLOGY make a profit or a loss?

S.M.B. TECHNOLOGY's most recently filed annual accounts (fiscal year ending 31 Dec 2025) reported a profit of €2,514,734.

When did S.M.B. TECHNOLOGY last file annual accounts?

S.M.B. TECHNOLOGY's most recently filed annual accounts cover the fiscal year ending 31 Dec 2025.

Is S.M.B. TECHNOLOGY B Corp certified?

We have no B Corp certification on file for S.M.B. TECHNOLOGY.

Does S.M.B. TECHNOLOGY hold Fairtrade certification?

No, S.M.B. TECHNOLOGY does not currently hold Fairtrade certification.

S.M.B. TECHNOLOGY

Q: When was S.M.B. TECHNOLOGY founded?

S.M.B. TECHNOLOGY was founded on 26 Aug 1987, making it 39 years old.

Q: What does S.M.B. TECHNOLOGY do?

S.M.B. TECHNOLOGY's registered main activities are Manufacture of medicaments, Manufacture of other pharmaceutical products, Wholesale of pharmaceutical and medical goods, Retail sale of pharmaceutical products, Retail sale of other food n.e.c., Wholesale of perfume and cosmetics, and Systematic studies and creative efforts undertaken in various types of math research and development and natural sciences (physics, astronomy, chemistry, medical sciences, biology, etc.).

BE 0431.842.812

Copied!

NV/SA

Status

Active

Founded

26 Aug 1987

Size

Large · 129 FTE

Age

39 yrs

Main activity

Manufacture of medicaments

Activities

7 activities

Manufacture of medicamentsManufacture of other pharmaceutical productsWholesale of pharmaceutical and medical goodsRetail sale of pharmaceutical productsRetail sale of other food n.e.c.Wholesale of perfume and cosmeticsSystematic studies and creative efforts undertaken in various types of math research and development and natural sciences (physics, astronomy, chemistry, medical sciences, biology, etc.)

Financials

Turnover2025

€94.5M+11.1%

Profit / Loss2025

€2.5M-34.4%

Equity2025

€19.6M+14.8%

2025	2024	2023	2022
€94,515,569+11.1%	€85,098,045+11.8%	€76,094,552+10.2%	€69,073,793
€2,514,734-34.4%	€3,830,878+918.1%	€376,267+114.9%	€175,097
€19,561,356+14.8%	€17,046,622+29%	€13,215,742+2.9%	€12,839,475
€37,288,228-14.2%	€43,455,310-1%	€43,916,303+33.5%	€32,899,300
€10,256,544-38.7%	€16,720,835+63.2%	€10,242,923-28.3%	€14,277,314
129+2.4%	126+5.9%	119-2.5%	122
€732,679+8.5%	€675,381+5.6%	€639,450+12.9%	€566,179

Frequently asked questions

01What is S.M.B. TECHNOLOGY's official registered name?

S.M.B. TECHNOLOGY.

02What is S.M.B. TECHNOLOGY's enterprise number (VAT number)?

BE 0431.842.812.

03What is S.M.B. TECHNOLOGY's legal form?

Naamloze vennootschap (NV) / Société anonyme (SA).

04When was S.M.B. TECHNOLOGY founded?

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

	2025	2024	2023	2022
Income statement
	€94,515,569+11.1%	€85,098,045+11.8%	€76,094,552+10.2%	€69,073,793
	€9,593,919+6.3%	€9,025,491+7.2%	€8,418,229+7.6%	€7,820,879
	€2,620,002-23.5%	€3,424,471+920.7%	€335,498+28.5%	€261,055
	€2,514,734-34.4%	€3,830,878+918.1%	€376,267+114.9%	€175,097
	€691,396+8.7%	€635,861+38.4%	€459,363+59.5%	€288,041
Profitability
	2.7%-40.9%	4.5%+810.4%	0.5%+95.1%	0.3%
	12.9%-42.8%	22.5%+689.3%	2.8%+108.8%	1.4%
	4.4%-30.1%	6.3%+861.4%	0.7%+72%	0.4%
Solvency
	€56,849,584-6%	€60,501,932+5.9%	€57,132,045+24.9%	€45,738,775
	€8,463,935+13.6%	€7,451,965+21.2%	€6,148,879-10.3%	€6,856,154
	€1,541,5280%	€1,541,528-44.8%	€2,791,5280%	€2,791,528
	€19,561,356+14.8%	€17,046,622+29%	€13,215,742+2.9%	€12,839,475
	34.4%+22.1%	28.2%+21.8%	23.1%-17.6%	28.1%
	€37,288,228-14.2%	€43,455,310-1%	€43,916,303+33.5%	€32,899,300
	1.91-25.2%	2.55-23.3%	3.32+29.7%	2.56
	8791.95	—	—	43509.17
Liquidity
	€10,256,544-38.7%	€16,720,835+63.2%	€10,242,923-28.3%	€14,277,314
	€24,610,999+13.5%	€21,690,996+39.1%	€15,596,129-11.6%	€17,647,398
	€35,208,348-13.8%	€40,824,150-4.1%	€42,578,015+59.4%	€26,706,802
	€37,277,582-14.2%	€43,435,474-1%	€43,885,696+33.4%	€32,893,003
	0.98+22.9%	0.80-7%	0.86+30.2%	0.66
	€9,501,538+20%	€7,918,223+99%	€3,978,485+30.6%	€3,046,302
Efficiency
	95 days+2.2%	93 days+24.4%	75 days-19.8%	93 days
	155 days-24.1%	204 days-12.1%	232 days+43%	162 days
Profit appropriation
	—	—	—	€10,000,000
	€6,613,573+17.8%	€5,613,698+21.7%	€4,613,700+27.7%	€3,613,825
	€10,444,058+17%	€8,929,199+46.4%	€6,098,317-9.3%	€6,721,925

Sources

NBB — Nationale Bank van België

	2025	2024	2023	2022
Income statement
	€94,515,569+11.1%	€85,098,045+11.8%	€76,094,552+10.2%	€69,073,793
	€9,593,919+6.3%	€9,025,491+7.2%	€8,418,229+7.6%	€7,820,879
	€2,620,002-23.5%	€3,424,471+920.7%	€335,498+28.5%	€261,055
	€2,514,734-34.4%	€3,830,878+918.1%	€376,267+114.9%	€175,097
	€691,396+8.7%	€635,861+38.4%	€459,363+59.5%	€288,041
Profitability
	2.7%-40.9%	4.5%+810.4%	0.5%+95.1%	0.3%
	12.9%-42.8%	22.5%+689.3%	2.8%+108.8%	1.4%
	4.4%-30.1%	6.3%+861.4%	0.7%+72%	0.4%
Solvency
	€56,849,584-6%	€60,501,932+5.9%	€57,132,045+24.9%	€45,738,775
	€8,463,935+13.6%	€7,451,965+21.2%	€6,148,879-10.3%	€6,856,154
	€1,541,5280%	€1,541,528-44.8%	€2,791,5280%	€2,791,528
	€19,561,356+14.8%	€17,046,622+29%	€13,215,742+2.9%	€12,839,475
	34.4%+22.1%	28.2%+21.8%	23.1%-17.6%	28.1%
	€37,288,228-14.2%	€43,455,310-1%	€43,916,303+33.5%	€32,899,300
	1.91-25.2%	2.55-23.3%	3.32+29.7%	2.56
	8791.95	—	—	43509.17
Liquidity
	€10,256,544-38.7%	€16,720,835+63.2%	€10,242,923-28.3%	€14,277,314
	€24,610,999+13.5%	€21,690,996+39.1%	€15,596,129-11.6%	€17,647,398
	€35,208,348-13.8%	€40,824,150-4.1%	€42,578,015+59.4%	€26,706,802
	€37,277,582-14.2%	€43,435,474-1%	€43,885,696+33.4%	€32,893,003
	0.98+22.9%	0.80-7%	0.86+30.2%	0.66
	€9,501,538+20%	€7,918,223+99%	€3,978,485+30.6%	€3,046,302
Efficiency
	95 days+2.2%	93 days+24.4%	75 days-19.8%	93 days
	155 days-24.1%	204 days-12.1%	232 days+43%	162 days
Profit appropriation
	—	—	—	€10,000,000
	€6,613,573+17.8%	€5,613,698+21.7%	€4,613,700+27.7%	€3,613,825
	€10,444,058+17%	€8,929,199+46.4%	€6,098,317-9.3%	€6,721,925

2025

2024

2023

2022

Income statement

€94,515,569+11.1%

€85,098,045+11.8%

€76,094,552+10.2%

€69,073,793

€9,593,919+6.3%

€9,025,491+7.2%

€8,418,229+7.6%

€7,820,879

€2,620,002-23.5%

€3,424,471+920.7%

€335,498+28.5%

€261,055

€2,514,734-34.4%

€3,830,878+918.1%

€376,267+114.9%

€175,097

€691,396+8.7%

€635,861+38.4%

€459,363+59.5%

€288,041

Profitability

2.7%-40.9%

4.5%+810.4%

0.5%+95.1%

0.3%

12.9%-42.8%

22.5%+689.3%

2.8%+108.8%

1.4%

4.4%-30.1%

6.3%+861.4%

0.7%+72%

0.4%

Solvency

€56,849,584-6%

€60,501,932+5.9%

€57,132,045+24.9%

€45,738,775

€8,463,935+13.6%

€7,451,965+21.2%

€6,148,879-10.3%

€6,856,154

€1,541,5280%

€1,541,528-44.8%

€2,791,5280%

€2,791,528

€19,561,356+14.8%

€17,046,622+29%

€13,215,742+2.9%

€12,839,475

34.4%+22.1%

28.2%+21.8%

23.1%-17.6%

28.1%

€37,288,228-14.2%

€43,455,310-1%

€43,916,303+33.5%

€32,899,300

1.91-25.2%

2.55-23.3%

3.32+29.7%

2.56

8791.95

—

43509.17

Liquidity

€10,256,544-38.7%

€16,720,835+63.2%

€10,242,923-28.3%

€14,277,314

€24,610,999+13.5%

€21,690,996+39.1%

€15,596,129-11.6%

€17,647,398

€35,208,348-13.8%

€40,824,150-4.1%

€42,578,015+59.4%

€26,706,802

€37,277,582-14.2%

€43,435,474-1%

€43,885,696+33.4%

€32,893,003

0.98+22.9%

0.80-7%

0.86+30.2%

0.66

€9,501,538+20%

€7,918,223+99%

€3,978,485+30.6%

€3,046,302

Efficiency

95 days+2.2%

93 days+24.4%

75 days-19.8%

93 days

155 days-24.1%

204 days-12.1%

232 days+43%

162 days

Profit appropriation

—

€10,000,000

€6,613,573+17.8%

€5,613,698+21.7%

€4,613,700+27.7%

€3,613,825

€10,444,058+17%

€8,929,199+46.4%

€6,098,317-9.3%

€6,721,925

S.M.B. TECHNOLOGY

Activities

Financials

Frequently asked questions

All locations

All locations